Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.08
Delayed Data
As of Feb 23
 +0.15 / +3.04%
Today’s Change
4.01
Today|||52-Week Range
8.38
+9.25%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Keryx Biopharmaceuticals Inc have a median target of 7.00, with a high estimate of 9.00 and a low estimate of 5.00. The median estimate represents a +37.80% increase from the last price of 5.08.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Hold stock in Keryx Biopharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.17
Sales
$17.5M
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 15.20%
 
 
 
 
 
 
Growthannually 58.24%
 
 
 
 
 
 

Sales

Growthquarterly 16.87%
 
 
 
 
 
 
Growthannually 80.22%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.